Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncytoskeletal anchor activity

ANK2 ANK3 MAP1A

2.88e-0524503GO:0008093
GeneOntologyMolecularFunctionspectrin binding

ANK2 ANK3 KIF3A

8.37e-0534503GO:0030507
GeneOntologyMolecularFunctionphosphorylation-dependent protein binding

ANK2 ANK3

2.73e-0410502GO:0140031
GeneOntologyBiologicalProcessaxonal transport

ANK3 MAP1A DCTN1 KIF3A

3.27e-0575504GO:0098930
GeneOntologyBiologicalProcessestablishment or maintenance of cell polarity

DOCK2 SLC9A1 ABL2 ANK3 DCTN1 KIF3A

3.54e-05257506GO:0007163
GeneOntologyCellularComponentT-tubule

SLC9A1 ANK2 ANK3 PRKCE

3.52e-0579494GO:0030315
GeneOntologyCellularComponentintercalated disc

SLC9A1 ANK2 ANK3

5.45e-0468493GO:0014704
GeneOntologyCellularComponentpostsynaptic density

PJA2 ARHGAP32 ANK2 ANK3 MAP1A PCLO

6.22e-04451496GO:0014069
GeneOntologyCellularComponentasymmetric synapse

PJA2 ARHGAP32 ANK2 ANK3 MAP1A PCLO

8.33e-04477496GO:0032279
GeneOntologyCellularComponentsarcolemma

SLC9A1 ANK2 ANK3 PRKCE

1.02e-03190494GO:0042383
GeneOntologyCellularComponentpostsynaptic specialization

PJA2 ARHGAP32 ANK2 ANK3 MAP1A PCLO

1.10e-03503496GO:0099572
GeneOntologyCellularComponentcostamere

ANK2 ANK3

1.21e-0322492GO:0043034
GeneOntologyCellularComponentneuron to neuron synapse

PJA2 ARHGAP32 ANK2 ANK3 MAP1A PCLO

1.34e-03523496GO:0098984
GeneOntologyCellularComponentcell-cell contact zone

SLC9A1 ANK2 ANK3

1.40e-0394493GO:0044291
GeneOntologyCellularComponentaxon initial segment

ANK3 MAP1A

2.10e-0329492GO:0043194
GeneOntologyCellularComponentneuromuscular junction

ANK3 PCLO PRKCE

2.31e-03112493GO:0031594
GeneOntologyCellularComponentpostsynapse

PJA2 ARHGAP32 ABL2 ANK2 ANK3 MAP1A PCLO KIF3A

2.35e-031018498GO:0098794
GeneOntologyCellularComponentribbon synapse

PCLO KIF3A

2.55e-0332492GO:0097470
DomainZU5

ANK2 ANK3

2.40e-049492SM00218
DomainSH3

DOCK2 ARHGAP32 ABL2 ARHGAP10 SH3KBP1

2.49e-04216495SM00326
DomainSH3

DOCK2 ARHGAP32 ABL2 ARHGAP10 SH3KBP1

2.49e-04216495PS50002
DomainSH3_domain

DOCK2 ARHGAP32 ABL2 ARHGAP10 SH3KBP1

2.71e-04220495IPR001452
DomainZU5

ANK2 ANK3

2.99e-0410492PS51145
DomainZU5

ANK2 ANK3

4.38e-0412492PF00791
DomainZU5_dom

ANK2 ANK3

4.38e-0412492IPR000906
DomainSH3_1

ARHGAP32 ABL2 ARHGAP10 SH3KBP1

8.93e-04164494PF00018
DomainSH3_9

ARHGAP32 ARHGAP10 SH3KBP1

1.12e-0378493PF14604
DomainGRAM

GRAMD2A OXR1

1.51e-0322492PF02893
DomainGRAM

GRAMD2A OXR1

1.51e-0322492IPR004182
DomainDEATH

ANK2 ANK3

2.27e-0327492SM00005
DomainDeath

ANK2 ANK3

3.38e-0333492PF00531
DomainDeath_domain

ANK2 ANK3

4.46e-0338492IPR000488
DomainDEATH_DOMAIN

ANK2 ANK3

4.46e-0338492PS50017
Domain-

HIVEP1 HIVEP2 KLF6 ZNF827 ZFHX2 DZIP1

8.36e-036794963.30.160.60
DomainHMG_box

KMT2C TOX2

8.53e-0353492PF00505
DomainHMG

KMT2C TOX2

8.85e-0354492SM00398
Domainzf-C2H2

HIVEP1 HIVEP2 KLF6 ZNF827 ZFHX2 DZIP1

9.19e-03693496PF00096
DomainZnf_C2H2/integrase_DNA-bd

HIVEP1 HIVEP2 KLF6 ZNF827 ZFHX2 DZIP1

9.26e-03694496IPR013087
DomainLaminin_G

FAT4 COL12A1

1.02e-0258492IPR001791
DomainRhoGAP

ARHGAP32 ARHGAP10

1.15e-0262492SM00324
DomainRhoGAP

ARHGAP32 ARHGAP10

1.19e-0263492PF00620
DomainRHOGAP

ARHGAP32 ARHGAP10

1.23e-0264492PS50238
Pubmed

A human MAP kinase interactome.

KMT2C ARHGAP32 SLC9A1 HIVEP1 HIVEP2 ABL2 ANK3 MAP1A ATF7IP PRKCE DCTN1 KIF3A

3.64e-12486501220936779
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

EPS15L1 ABL2 ANK2 MAP1A OXR1 PCLO SH3KBP1 PRKCE

3.38e-0834750817114649
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

ARHGAP32 EPS15L1 ANK2 ANK3 MAP1A OXR1 PCLO SH3KBP1 KIAA1549 SRP72 PRKCE DCTN1 KIF3A

7.86e-081431501337142655
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

KMT2C EPS15L1 HIVEP2 GTF2I PTPRB ANK3 ZNF827 ARHGAP10 VPS13C FNBP4 ZFHX2 PRKCE CREB3L2

1.24e-071489501328611215
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

ARHGAP32 ABL2 ANK2 ANK3 MAP1A PCLO PRKCE

1.55e-0728150728706196
Pubmed

Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.

FAT4 ANK3 PCLO

4.58e-071150320351715
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

ARHGAP32 EPS15L1 NYAP2 ANK2 ANK3 ATF7IP SH3KBP1 PRKCE DCTN1 KIF3A

9.51e-07963501028671696
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

ARHGAP32 FNBP4 KIAA1549 CUL9 TASOR

1.25e-0613050512421765
Pubmed

Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.

ARHGAP32 ANK2 ANK3 SH3KBP1 PRKCE DCTN1

1.62e-0625150627507650
Pubmed

The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.

ANK2 ANK3

2.03e-06250211781319
Pubmed

Structural basis of diverse membrane target recognitions by ankyrins.

ANK2 ANK3

2.03e-06250225383926
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

PJA2 ARHGAP32 EPS15L1 NYAP2 ANK2 ANK3 MAP1A PCLO SH3KBP1 TACC2

4.26e-061139501036417873
Pubmed

Human ankyrins and their contribution to disease biology: An update.

ANK2 ANK3

6.07e-06350233410423
Pubmed

A PIK3C3-ankyrin-B-dynactin pathway promotes axonal growth and multiorganelle transport.

ANK2 DCTN1

6.07e-06350225533844
Pubmed

Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release.

ANK3 KIF3A

6.07e-06350219934039
Pubmed

The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells.

ANK2 ANK3

6.07e-06350215611082
Pubmed

[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway.

SLC9A1 PRKCE

6.07e-06350225372487
Pubmed

Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.

ANK2 ANK3

6.07e-06350234289389
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

COL12A1 HIVEP1 ANK2 SRP72 DZIP1 DCTN1 KIF3A

6.85e-0649750723414517
Pubmed

Ank3-dependent SVZ niche assembly is required for the continued production of new neurons.

ANK3 KIF3A

1.21e-05450221745638
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

EPS15L1 HIVEP2 HEATR6 ANK2 ANK3 OXR1 CUL9 DZIP1 DCTN1 KIF3A

1.22e-051285501035914814
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

FAT4 EPS15L1 GTF2I ANK3 VPS13C ATF7IP MUC16 TASOR

1.40e-0577750835844135
Pubmed

CK2-regulated schwannomin-interacting protein IQCJ-SCHIP-1 association with AnkG contributes to the maintenance of the axon initial segment.

ANK2 ANK3

2.02e-05550225950943
Pubmed

Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments.

DCTN1 KIF3A

2.02e-05550222261744
Pubmed

Glial ankyrins facilitate paranodal axoglial junction assembly.

ANK2 ANK3

2.02e-05550225362471
Pubmed

An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.

ANK2 ANK3

2.02e-05550219109891
Pubmed

A distal axonal cytoskeleton forms an intra-axonal boundary that controls axon initial segment assembly.

ANK2 KIF3A

2.02e-05550222632975
Pubmed

Kif3a interacts with Dynactin subunit p150 Glued to organize centriole subdistal appendages.

DCTN1 KIF3A

3.03e-05650223386061
Pubmed

In vivo assembly of the axon initial segment in motor neurons.

ANK2 ANK3

3.03e-05650223728480
Pubmed

Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.

DOCK2 EPS15L1 PTPRB SH3KBP1

4.11e-0513350415144186
Pubmed

Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice.

ANK2 ANK3

4.23e-0575027495297
Pubmed

In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse.

DCTN1 KIF3A

4.23e-05750216632484
Pubmed

A census of human transcription factors: function, expression and evolution.

HIVEP1 HIVEP2 KLF6 KIAA1549 ZFHX2 DLX3 TOX2 CREB3L2

4.25e-0590850819274049
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

EPS15L1 GTF2I ANK2 MAP1A ATF7IP TACC2 DCTN1 TASOR

5.19e-0593450833916271
Pubmed

A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.

KMT2C HIVEP1 HIVEP2 GTF2I KLF6 ZFHX2 TACC2

6.63e-0570950722988430
Pubmed

Potent and specific Atg8-targeting autophagy inhibitory peptides from giant ankyrins.

ANK2 ANK3

7.25e-05950229867141
Pubmed

RPGR-ORF15, which is mutated in retinitis pigmentosa, associates with SMC1, SMC3, and microtubule transport proteins.

DCTN1 KIF3A

9.05e-051050216043481
Pubmed

Cell organization, growth, and neural and cardiac development require αII-spectrin.

ANK2 ANK3

9.05e-051050222159418
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

KMT2C NYAP2 VPS13C FNBP4 KIAA1549 DZIP1

1.08e-0452950614621295
Pubmed

Loss of alpha-tubulin polyglutamylation in ROSA22 mice is associated with abnormal targeting of KIF1A and modulated synaptic function.

MAP1A KIF3A

1.10e-041150217360631
Pubmed

Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.

EPS15L1 SH3KBP1

1.10e-041150215962011
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

KMT2C EPS15L1 GTF2I ANK3 FNBP4 DCTN1

1.33e-0454950638280479
Pubmed

Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.

EPS15L1 SH3KBP1

1.56e-041350212218189
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

GRAMD2A KMT2C EPS15L1 HEG1 HIVEP2 ZNF827 CUL9 DCTN1

1.66e-04110550835748872
Pubmed

Human transcription factor protein interaction networks.

KMT2C ARHGAP32 HIVEP1 GTF2I KLF6 ATF7IP SH3KBP1 CUL9 SRP72

1.78e-04142950935140242
Pubmed

Functional proteomics mapping of a human signaling pathway.

HIVEP1 ANK3 ATF7IP FNBP4 SRP72 DCTN1

1.98e-0459150615231748
Pubmed

ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease.

ANK2 OXR1 PCLO DCTN1

2.06e-0420250433601422
Pubmed

Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth.

ANK2 ANK3

2.10e-041550230562487
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

PJA2 ARHGAP32 HIVEP1 HIVEP2 ABL2 PRKCE DZIP1

2.20e-0486150736931259
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

KMT2C HIVEP1 KLF6 ATF7IP PCLO

2.66e-0439850535016035
Pubmed

Kv7/KCNQ potassium channels in cortical hyperexcitability and juvenile seizure-related death in Ank2-mutant mice.

ANK2 ANK3

3.05e-041850237321992
Pubmed

Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain.

ANK2 ANK3

3.05e-041850231910261
Pubmed

Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.

DOCK2 EPS15L1 MAP1A SH3KBP1

3.16e-0422650431452512
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

HIVEP1 GTF2I ATF7IP DCTN1 TASOR

3.33e-0441850534709266
Pubmed

Interactome Analysis Reveals Regulator of G Protein Signaling 14 (RGS14) is a Novel Calcium/Calmodulin (Ca2+/CaM) and CaM Kinase II (CaMKII) Binding Partner.

PTPRB ANK2 ANK3 PCLO

3.55e-0423350429518331
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

EPS15L1 HIVEP1 GTF2I ATF7IP FNBP4 SRP72 TASOR

4.08e-0495450736373674
Pubmed

DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.

MAP1A ATF7IP

4.59e-042250212812986
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

ARHGAP32 EPS15L1 ABL2 ANK2 ANK3 SRP72

5.17e-0470850639231216
Pubmed

Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks.

EPS15L1 SH3KBP1 FNBP4

5.56e-0411150322558309
Pubmed

Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.

ARHGAP32 MAP1A ARHGAP10 PCLO CUL9

7.22e-0449650531343991
Pubmed

Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.

ANK3 KLF6 VPS13C

8.41e-0412850330995482
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

PJA2 MAP1A ZNF827 ARHGAP10 KIAA1549 CUL9 TARBP2

1.03e-03111650731753913
Pubmed

DNA Damage Regulates Translation through β-TRCP Targeting of CReP.

HIVEP1 HIVEP2

1.17e-033550226091241
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

PJA2 ANK2 ANK3 FNBP4 KIAA1549 DZIP1 DCTN1 TARBP2

1.19e-03148750833957083
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

ABL2 ANK2 SH3KBP1 CUL9

1.29e-0332950417474147
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

ARHGAP32 EPS15L1 SLC9A1 ANK3 SH3KBP1

1.29e-0356550525468996
Pubmed

Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.

ANK2 DCTN1

1.31e-033750227565344
Pubmed

Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.

ANK2 DCTN1 KIF3A

1.35e-0315150317043677
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

PJA2 ARHGAP32 EPS15L1 ABL2 VPS13C DCTN1

1.36e-0385350628718761
InteractionKCTD13 interactions

PJA2 ARHGAP32 EPS15L1 ANK2 ANK3 MAP1A OXR1 PCLO SH3KBP1 KIAA1549 SRP72 PRKCE DCTN1 KIF3A

3.65e-0613944914int:KCTD13
InteractionAGAP2 interactions

ABL2 ANK2 ANK3 MAP1A PCLO PRKCE

1.15e-05210496int:AGAP2
GeneFamilyFibronectin type III domain containing

COL12A1 PTPRB ATF7IP

2.55e-03160313555
GeneFamilyRho GTPase activating proteins|BCH domain containing

ARHGAP32 ARHGAP10

3.31e-0350312721
CoexpressionHEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS

ANK2 ANK3 PCLO KIAA1549 PRKCE

6.13e-06136505MM407
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

PJA2 HEG1 HIVEP1 HIVEP2 KLF6 TASOR CREB3L2

2.77e-05466507M13522
CoexpressionGSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN

DOCK2 HEATR6 ANK3 MUC16 TAF1D

3.58e-05196505M4973
CoexpressionGSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN

EPS15L1 KLF6 ARHGAP10 FNBP4 PRKCE

3.94e-05200505M3975
CoexpressionHE_LIM_SUN_FETAL_LUNG_C2_ADC_2_CELL

SLC9A1 HIVEP1 HIVEP2 ARHGAP10

4.51e-05103504M45742
CoexpressionDUTERTRE_ESTRADIOL_RESPONSE_24HR_DN

FAT4 SLC9A1 HIVEP2 ANK3 KLF6 KIF3A CREB3L2

4.55e-05504507M2157
CoexpressionMURARO_PANCREAS_BETA_CELL

PJA2 KMT2C HIVEP2 MAP1A VPS13C PCLO CASR KIF3A CREB3L2

6.62e-05946509M39169
CoexpressionPEREZ_TP53_TARGETS

GRAMD2A HEG1 ANK3 ARHGAP10 VPS13C KIAA1549 DLX3 DZIP1 TOX2 CREB3L2

7.56e-0512015010M4391
CoexpressionFLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN

PJA2 GTF2I ANK2 ANK3 DZIP1 KIF3A CREB3L2

8.15e-05553507M1475
CoexpressionLEE_RECENT_THYMIC_EMIGRANT

HEG1 OXR1 ZNF827 VPS13C TOX2

9.17e-05239505M17496
CoexpressionIVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR

ARHGAP32 ZNF827 FNBP4 KIAA1549 PRKCE KIF3A TAF1D

1.03e-04574507M8215
CoexpressionBILD_HRAS_ONCOGENIC_SIGNATURE

KMT2C SLC9A1 COL12A1 KLF6 ZNF827

1.18e-04252505M12029
CoexpressionIVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR

ARHGAP32 ZNF827 FNBP4 KIAA1549 PRKCE KIF3A TAF1D

1.35e-04600507MM1025
CoexpressionDURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS

GFY GTF2I PCLO KIF3A

1.48e-04140504M39288
CoexpressionHE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL

ARHGAP32 COL12A1 ANK2 PCLO ZFHX2 PRKCE

1.60e-04429506M45694
CoexpressionKOINUMA_TARGETS_OF_SMAD2_OR_SMAD3

KMT2C ARHGAP32 SLC9A1 COL12A1 GTF2I PTPRB KLF6 VPS13C

1.80e-04843508M2356
CoexpressionGSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN

DOCK2 HIVEP2 SH3KBP1 FNBP4

2.30e-04157504M7733
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

PJA2 ARHGAP10 VPS13C ATF7IP DZIP1 TASOR KIF3A

2.34e-04656507M18979
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000

PJA2 KMT2C HEG1 ABL2 SRP72 KIF3A

5.21e-07127506gudmap_developingGonad_e16.5_epididymis_1000_k4
CoexpressionAtlasalpha beta T cells, T.4Mem44h62l.LN, CD4 TCRb CD44hi CD62Llo, Lymph Node, avg-3

HEG1 HIVEP2 ZNF827 ARHGAP10 SH3KBP1 DZIP1 TOX2

1.57e-05346507GSM538368_500
ToppCellrenal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 KLF6 ARHGAP10 KIAA1549 TACC2

2.25e-06189505a48df46274d51e84ffb40264646de7346104efb9
ToppCellLPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE TOX2

2.44e-0619250504f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE TOX2

2.44e-06192505c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCellFibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

SSC5D ANK3 MAP1A TACC2 DLX3

2.50e-061935058f4bf9a2fbedae35432dad96730b00c70185874c
ToppCellLPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE TOX2

2.50e-0619350502f633b016ab19bfa65bfd0cf32f000549a62148
ToppCellLPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE TOX2

2.50e-061935055122b1ffba42de190061be34ecdc6176f84e56a3
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGAP32 ANK2 ANK3 MAP1A SH3KBP1

2.56e-06194505ba529c051f248d29f4222f4bc9801ba233859093
ToppCellLPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE TOX2

2.56e-0619450543f92b0533e26633dc94cce554045d641ef8fd76
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE TOX2

2.56e-061945050b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellLPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE TOX2

2.56e-061945051d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCellprimary_visual_cortex-Neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PJA2 ANK3 OXR1 PCLO PRKCE

2.69e-061965058efc2b3a95f57c31be203ac781b2098d4909297f
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ARHGAP32 HIVEP2 OXR1 PCLO PRKCE

2.83e-061985058ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCellBronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SSC5D FAT4 COL12A1 ANK2 MAP1A

2.90e-0619950521335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

KMT2C FAT4 HEG1 COL12A1 PTPRB

2.97e-06200505dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellTracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FAT4 HEG1 PTPRB ABL2 TOX2

2.97e-062005055ec31c1be6bcc4124e1489d136570f3de33cc2e9
ToppCellTracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP32 ANK3 PCLO MUC16 TACC2

2.97e-06200505d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCellLPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type

SSC5D MAP1A ARHGAP10 TACC2 DZIP1

2.97e-062005058bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

KMT2C HIVEP2 ANK3 ATF7IP

2.83e-051565041545169694f686d28648a68b552c2ae606599d66
ToppCellIPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class

ANK2 PCLO MUC16 TACC2

3.12e-05160504d65d19f4fae60836bfd4303a1bb7de34e9d83e35
ToppCellIPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class

ANK2 PCLO MUC16 TACC2

3.20e-05161504f1cd5c938cdc08ad8995371b72493850a6cf277a
ToppCellControl-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations)

HEG1 COL12A1 ANK3 TACC2

3.96e-05170504e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells)

PCLO MUC16 DLX3 SERTM1

4.24e-05173504e05cddf5bf63cf419343ff229453327519765be8
ToppCell367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

PCLO MUC16 DLX3 SERTM1

4.24e-051735043d7c281a1a9f183a5a861d1a9c7b50d216535893
ToppCellAT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

HEG1 COL12A1 TACC2 SERTM1

4.24e-051735043afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells)

PCLO MUC16 DLX3 SERTM1

4.24e-0517350474ad5ed33821b8816c9c8e67c50ee4496ba18e2f
ToppCell367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

PCLO MUC16 DLX3 SERTM1

4.24e-051735043aa90578371039f81b7c6fa873ec70f8f2bc7dfa
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VPS13C PCLO KIAA1549 ZFHX2

4.33e-05174504f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCellCOPD-Myeloid-pDC|World / Disease state, Lineage and Cell class

HIVEP1 MAP1A TOX2 CREB3L2

4.33e-05174504be8227398300711ccda5ecc41ad34064bb246b19
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SSC5D FAT4 COL12A1 ARHGAP10

4.43e-051755041799a7be623dc3bf53ba580a7c47d2619969d708
ToppCellIPF-Myeloid-pDC|World / Disease state, Lineage and Cell class

HIVEP1 MAP1A TOX2 CREB3L2

4.43e-05175504a06785a4ded01adfd29ca4c20f7759eccbe274cb
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 COL12A1 ARHGAP10 CREB3L2

4.53e-051765049bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 COL12A1 ARHGAP10 CREB3L2

4.53e-051765043f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HEG1 VPS13C ATF7IP TASOR

4.53e-05176504749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellIPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class

HIVEP1 MAP1A TOX2 CREB3L2

4.73e-051785048d9e28492e1f157bac3308aa947fd864ca16d277
ToppCellCOPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class

HIVEP1 MAP1A TOX2 CREB3L2

4.84e-0517950429b058c5e33fda9f0d738c074bdb67ff16b9b6d5
ToppCellIPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class

HIVEP1 MAP1A TOX2 CREB3L2

4.94e-051805040f8567aa835d4e3a52f6631ae15216eca18a030c
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAT4 HEG1 PTPRB TOX2

5.05e-051815044d7793026373cbcf04b15c77f95f1025d07d4c00
ToppCelldroplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HEG1 PTPRB TOX2 CREB3L2

5.05e-05181504136b0c60680068838d184d32aa99d7bea8718dbc
ToppCellClub-club-7|World / Class top

DOCK2 MAP1A SH3KBP1

5.13e-0564503df413c5328966480479c41826461c4d817fbe33d
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAT4 HEG1 PTPRB TOX2

5.27e-051835043427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCellCOVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type

GRAMD2A COL12A1 NYAP2 TACC2

5.27e-05183504942530449e9c6583705eeb8f6f12621daea57252
ToppCellAT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

GRAMD2A HEG1 COL12A1 PCLO

5.27e-051835046821dca076318115d360ff426eb1218cfe104063
ToppCell343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

HEG1 COL12A1 KLF6 SERTM1

5.38e-05184504c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KLF6 VPS13C SH3KBP1 TASOR

5.38e-051845041154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

HEG1 COL12A1 KLF6 SERTM1

5.38e-051845041ed558a88215b248431c524ea16f13d9022ae98c
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass

COL12A1 ANK2 DZIP1 CREB3L2

5.50e-05185504427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCellEndothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

FAT4 HEG1 PTPRB TOX2

5.50e-05185504dee0b7ba2f338f0979d2306aedf52ac35a36b60c
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 HEG1 PTPRB TOX2

5.50e-05185504a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KMT2C VPS13C PCLO MUC16

5.61e-0518650423b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCellCOVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANK3 OXR1 PCLO CASR

5.73e-05187504d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor

PTPRB KIAA1549 PRKCE TOX2

5.85e-0518850402a62888e9db29d20133eeca1686d302545a39c9
ToppCellMesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor

SSC5D FAT4 COL12A1 DZIP1

5.97e-0518950444e37f88137bb249933eb615235b2cf2ae7f3925
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEG1 NYAP2 TOX2 SERTM1

5.97e-05189504979b7fa947538aa7ca4a219263da2575869a2caa
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 KLF6 CASR DZIP1

5.97e-051895048c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 KLF6 CASR DZIP1

5.97e-051895045d902a4660a27548764bf04c6de152b565da835c
ToppCellControl-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class

PTPRB KIAA1549 PRKCE TOX2

6.10e-051905047f3f419fffe02934b6f27b697f7a6401072491ed
ToppCellCOVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type

FAT4 HEG1 PTPRB TOX2

6.10e-051905041519f34d31fe0817184c5865a0bc9f0cb479b1a4
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 HEG1 PTPRB TOX2

6.10e-05190504f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

OXR1 CASR DZIP1 CREB3L2

6.10e-05190504cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCellEndothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

FAT4 HEG1 PTPRB CASR

6.22e-05191504f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass

COL12A1 ANK2 DZIP1 CREB3L2

6.22e-051915049bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCellLPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB TOX2

6.22e-051915044b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEG1 NYAP2 TOX2 SERTM1

6.35e-05192504f6ec683b2133b3095a1fcc06ca8605cf38f774b5
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEG1 NYAP2 TOX2 SERTM1

6.35e-05192504342842378c20267c5044bdd622515e8b9f895623
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEG1 NYAP2 TOX2 SERTM1

6.35e-05192504690b3d17c481159bc96b8bc7f6a66b51343ee858
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE

6.48e-05193504e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCellfacs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGAP32 ANK3 MAP1A SH3KBP1

6.48e-05193504d8ccfb780a75bdf9141f41fb29a076958601ebb4
ToppCellLPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE

6.48e-051935046e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 OXR1 PCLO CASR

6.48e-0519350482e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 OXR1 PCLO TACC2

6.48e-051935043866667dd221612589ae50f5c52f73a183a49ce6
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 HEG1 PTPRB TOX2

6.48e-05193504456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEG1 NYAP2 TOX2 SERTM1

6.61e-0519450452aebb0b563e2c2058e7f0554ae870e47692b163
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEG1 NYAP2 TOX2 SERTM1

6.61e-051945046ac759828c41ffa974ee82842162caa959351dd1
ToppCell3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NYAP2 ANK2 PCLO DLX3

6.61e-0519450415224fb3e7ca5bd1fb8c41f8275842f737014095
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 PTPRB KIAA1549 TOX2

6.61e-0519450471ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 HEG1 PTPRB TOX2

6.61e-05194504a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCell10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SSC5D ANK3 TACC2 DLX3

6.61e-0519450469362e13158033de44f90f3773db6c0f27de8cb3
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 OXR1 PCLO CASR

6.61e-051945045eaaa81f4b2535f983c424aaef00077089526a5c
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 PTPRB KIAA1549 TOX2

6.61e-0519450468004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEG1 NYAP2 TOX2 SERTM1

6.61e-051945045d0b0d8e96f0e0297a4dba70a05d87081a4eb323
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEG1 NYAP2 TOX2 SERTM1

6.61e-05194504bd06e2b8d8c06cddf2e4f58849b86e09013acae1
ToppCellLPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE

6.61e-0519450458f069efdefa0366033764446b9d6ffd4a17807e
ToppCellLPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 HEG1 PTPRB PRKCE

6.61e-05194504bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 PTPRB KIAA1549 TOX2

6.61e-0519450440842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCellASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

SSC5D FAT4 HEG1 PTPRB

6.74e-05195504304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 OXR1 PCLO CASR

6.74e-051955046477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCellcellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FAT4 HEG1 PTPRB TOX2

6.74e-0519550475db19c0371320ea5fce1d6de8c1b40b1e6a2e58
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HEG1 NYAP2 TOX2 SERTM1

6.74e-0519550498ca9f3aa36211dde1e6f7f3817b9418c95e583e
ToppCellfacs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL12A1 KIAA1549 PRKCE TOX2

6.74e-05195504cad21edd90bf3e2fefdf5773a59cb1a664a69ddd
ToppCellfacs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL12A1 KIAA1549 PRKCE TOX2

6.74e-051955047e0ef92059ff34e368d2324815f49b50e3ca7332
ToppCellASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

FAT4 PTPRB PRKCE TOX2

6.88e-0519650414dd6956ef420b660be0baf52a66960e57d75d16
ToppCellASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

FAT4 PTPRB PRKCE TOX2

6.88e-051965042b777a2026b56839112fd179f2db482c49f4594a
ToppCellfrontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PJA2 ANK3 OXR1 PCLO

6.88e-05196504de7d10da862f98894ce47244fbc992f4a12d63bb
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANK2 ANK3 OXR1 PCLO

6.88e-05196504eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCellCOVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type

FAT4 PTPRB PRKCE TOX2

6.88e-05196504ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCelldistal-1-Epithelial-Alveolar_Epithelial_Type_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

GRAMD2A COL12A1 NYAP2 SERTM1

7.01e-05197504d44b7dc7c6416ed9466889374c3ae39f43ac8bb6
ToppCellCOVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type

FAT4 PTPRB PRKCE TOX2

7.01e-051975047e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCellP03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SSC5D COL12A1 ANK2 CREB3L2

7.01e-051975042cec938caf6ffd031cea37277071487e59b2c71c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FAT4 COL12A1 ARHGAP10 CREB3L2

7.01e-051975049b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCellFibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

SSC5D COL12A1 ANK2 MAP1A

7.15e-051985044f4632f26a2043c5e4ab89031b4229b5dca1bd48
Drugprochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A

EPS15L1 HEG1 HIVEP1 HIVEP2 ABL2 KLF6

2.76e-061815062675_UP
DrugHydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; PC3; HT_HG-U133A

EPS15L1 HEG1 ABL2 ANK2 MAP1A CUL9

4.63e-061985066651_UP
DrugAC1L1KMJ

EPS15L1 SLC9A1 COL12A1 PTPRB ANK2 ANK3 PRKCE DCTN1

8.55e-06476508CID000030956
DiseaseAlzheimer's disease (implicated_via_orthology)

HIVEP1 HIVEP2 ANK2

1.26e-0457503DOID:10652 (implicated_via_orthology)
Diseasewellbeing measurement

FAT4 NYAP2 HIVEP1 HIVEP2 KLF6 PCLO FNBP4

1.57e-04692507EFO_0007869
Diseasejuvenile polyposis syndrome (implicated_via_orthology)

HIVEP1 HIVEP2

2.17e-0413502DOID:0050787 (implicated_via_orthology)
Diseaseasthma

EPS15L1 HIVEP1 HIVEP2 MUC16 CASR TASOR KIF3A

2.59e-04751507MONDO_0004979
Diseasenucleotide measurement

DOCK2 PTPRB PRKCE

2.62e-0473503EFO_0010513
Diseaseintellectual disability (implicated_via_orthology)

HIVEP2 ANK2 ATF7IP

2.84e-0475503DOID:1059 (implicated_via_orthology)
Diseaseglycerol measurement

FAT4 PCLO

8.91e-0426502EFO_0010115
DiseaseAbnormality of refraction

ARHGAP32 ANK3 PCLO DCTN1 KIF3A CREB3L2

9.32e-04673506HP_0000539
Diseasehematocrit

NYAP2 HIVEP1 HIVEP2 KLF6 ARHGAP10 PRKCE TASOR

1.50e-031011507EFO_0004348

Protein segments in the cluster

PeptideGeneStartEntry
KLDPFESSDPFSSSS

EPS15L1

701

Q9UBC2
ADTTSPETPDSSASK

DCTN1

101

Q14203
SDDTSKPFPRSNSTS

ABL2

771

P42684
SSSISSKSNSEDPFP

CASR

911

P41180
PDPSIVVTFKEDSSS

FAT4

136

Q6V0I7
SKDSPTLPESSVTDL

DLX3

26

O60479
DVSSNPFLPSDSSKT

KIAA1549

376

Q9HCM3
LAETPETSPESLSFS

ANK2

2236

Q01484
ETSPESLSFSPKKSE

ANK2

2241

Q01484
PYPSKEDTPTSSLDS

ARHGAP10

626

A1A4S6
EPTSSLATSFDSTPL

MUC16

2656

Q8WXI7
PISLSTEKETSFLSP

MUC16

3031

Q8WXI7
TIPPSIEKTSFSSSL

MUC16

6791

Q8WXI7
SPSSVLPDSETTKAT

MUC16

7491

Q8WXI7
VLDTSSEPKTSSSPN

MUC16

9771

Q8WXI7
FPDVPETTSSLATSL

MUC16

10531

Q8WXI7
SDTFFSLPITTESEP

PTPRB

1601

P23467
STPTSTSSDDVFVKP

KMT2C

1836

Q8NEZ4
ILTPDSSFSKSPESL

MAP1A

1316

P78559
SSPSEEDRSKSAPTS

PRKCE

336

Q02156
SSPSSPSDLAKLEST

PCLO

1401

Q9Y6V0
SESFLKPSTSETPLE

FAM221B

36

A6H8Z2
LEETSVSSPKGSSEP

HEATR6

636

Q6AI08
TESKSPSLVSLPTES

HEG1

791

Q9ULI3
TPTSPLEELTSLFSS

NYAP2

506

Q9P242
TDSSNEPPKTFTFDT

KIF3A

51

Q9Y496
SPTEDKSSKPSSFTE

ARHGAP32

871

A7KAX9
SPLSPTSSEAEFDKT

OXR1

161

Q8N573
STPSKPTSESFDLEL

DOCK2

1656

Q92608
PTSESFDLELASPKT

DOCK2

1661

Q92608
PTTDGPTKEFTLSAS

COL12A1

61

Q99715
SPETPKADSLTTSIS

GFY

101

I3L273
TETSPTKSPDSLEFS

ANK3

3041

Q12955
SESTFDRTFEPKSVP

ATF7IP

281

Q6VMQ6
TPDPEEESKSEASFS

CUL9

591

Q8IWT3
SSVDSTDSFFPSRKP

GRAMD2A

231

Q8IUY3
FETAIKESTSSKSPP

GTF2I

811

P78347
LSTDFPSTSIKTEPV

CREB3L2

116

Q70SY1
PEPKEAATSTLSSST

FNBP4

176

Q8N3X1
ASDSSSDSSFEPIPL

TAF1D

61

Q9H5J8
LTSSSLSSPDIFDSP

SH3KBP1

496

Q96B97
ELFPTSLSTSVDPSS

SERTM1

21

A2A2V5
SELDASKTVSSPPTS

SRP72

611

O76094
KELTSDPSTPSEVTS

SSC5D

1096

A1L4H1
KSSTITTPPFSSEEE

DZIP1

671

Q86YF9
FPSSPFTDTLKGTTE

TASOR

976

Q9UK61
DTFSSSTPSDPVTKD

ZFHX2

26

Q9C0A1
SKETSSPGTDDVFTP

SLC9A1

766

P19634
SAAPFSEPSSSEKES

VPS13C

1556

Q709C8
ESVDPFKTSSKTPSS

TACC2

2376

O95359
SPFTSNSKELLPSDS

ZNF827

771

Q17R98
KSATPSPSSSTQEEE

TOX2

206

Q96NM4
EDSSSFSPLDSSLPE

TARBP2

106

Q15633
KFPSDQSSKSTETPS

HIVEP2

1296

P31629
DSSLPSEPIFEKSET

PJA2

86

O43164
ETLLKSSFTPSSPEN

HIVEP1

526

P15822
SEELSPTAKFTSDPI

KLF6

116

Q99612